| Dr Mark Douglas Breithaupt, PHD | |
|
1100 Lincoln Ave Ste 394, San Jose, CA 95125 | |
| (408) 320-2747 | |
| (408) 320-2747 |
| Full Name | Dr Mark Douglas Breithaupt |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 1100 Lincoln Ave Ste 394, San Jose, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053436337 | NPI | - | NPPES |
| A 3812-3 | Other | HI | HMSA |
| 03451701 | Medicaid | HI |
| Entity Name | Community Clinic Of Maui, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528042561 PECOS PAC ID: 2466365440 Enrollment ID: O20040219000740 |
News Archive
The Influenza Specialist Group (ISG) is today warning that high rates of influenza outbreaks have been confirmed in QLD, SA and NSW, but there is still time for most Australians, especially those in at-risk groups, to protect themselves and those around them.
According to Statistics Sweden, 30 percent of all parents of young children in Sweden separate. Researchers at the University of Gothenburg have mapped the most important factors behind the separations and divorces - and offer five tips that can save the relationship.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China today reported financial results for the three months ended March 31, 2015.
Publicly-funded physician psychotherapy is only available to a fraction of those with urgent mental health needs in Ontario, according to a joint study by the Centre for Addiction and Mental Health (CAMH) and ICES published today in CMAJ Open.
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the European Commission (EC) has granted orphan drug designation to TxCell's investigational medicinal product Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of autoimmune uveitis.
› Verified 2 days ago
| Entity Name | Mark D Breithaupt Phd Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902115082 PECOS PAC ID: 8123208618 Enrollment ID: O20110216000359 |
News Archive
The Influenza Specialist Group (ISG) is today warning that high rates of influenza outbreaks have been confirmed in QLD, SA and NSW, but there is still time for most Australians, especially those in at-risk groups, to protect themselves and those around them.
According to Statistics Sweden, 30 percent of all parents of young children in Sweden separate. Researchers at the University of Gothenburg have mapped the most important factors behind the separations and divorces - and offer five tips that can save the relationship.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China today reported financial results for the three months ended March 31, 2015.
Publicly-funded physician psychotherapy is only available to a fraction of those with urgent mental health needs in Ontario, according to a joint study by the Centre for Addiction and Mental Health (CAMH) and ICES published today in CMAJ Open.
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the European Commission (EC) has granted orphan drug designation to TxCell's investigational medicinal product Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of autoimmune uveitis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Douglas Breithaupt, PHD Po Box 8396, San Jose, CA 95155-8396 Ph: (408) 320-2747 | Dr Mark Douglas Breithaupt, PHD 1100 Lincoln Ave Ste 394, San Jose, CA 95125 Ph: (408) 320-2747 |
News Archive
The Influenza Specialist Group (ISG) is today warning that high rates of influenza outbreaks have been confirmed in QLD, SA and NSW, but there is still time for most Australians, especially those in at-risk groups, to protect themselves and those around them.
According to Statistics Sweden, 30 percent of all parents of young children in Sweden separate. Researchers at the University of Gothenburg have mapped the most important factors behind the separations and divorces - and offer five tips that can save the relationship.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China today reported financial results for the three months ended March 31, 2015.
Publicly-funded physician psychotherapy is only available to a fraction of those with urgent mental health needs in Ontario, according to a joint study by the Centre for Addiction and Mental Health (CAMH) and ICES published today in CMAJ Open.
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the European Commission (EC) has granted orphan drug designation to TxCell's investigational medicinal product Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of autoimmune uveitis.
› Verified 2 days ago
Dr. Rethel E. Gill, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1927 Otoole Way, San Jose, CA 95131 Phone: 707-861-8276 | |
Christina Wing In Gee, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2039 Forest Ave Ste 201, San Jose, CA 95128 Phone: 408-358-8090 | |
Marie Roman-clifton, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 751 S Bascom Ave, Psychology Services-pm&r, San Jose, CA 95128 Phone: 408-885-4445 | |
Dr. Jennifer Gregg, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: Dept Of Psychology, One Washington Square, San Jose, CA 95192 Phone: 650-743-7230 | |
Mr. Donald B Dufford, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3880 S Bascom Ave, Suite 212, San Jose, CA 95124 Phone: 408-559-9088 Fax: 408-377-7833 | |
Dr. Sepideh Afrakhteh Katz, PH. D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3500 Zanker Road, San Jose, CA 95134 Phone: 408-451-6198 | |
Dr. Kelly Sue Lynch, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 2001 The Alameda, Momentum For Mental Health Service Team Adult Outpatie, San Jose, CA 95126 Phone: 408-261-7777 Fax: 408-259-2273 |